BiondVax Pharmaceuticals: Q2 Earnings Insights

BiondVax Pharmaceuticals: Q2 Earnings Insights

 

BiondVax Pharmaceuticals BVXV reported its Q2 earnings results on Thursday, August 25, 2022 at 07:10 AM.

Here's what investors need to know about the announcement.

Earnings

BiondVax Pharmaceuticals missed estimated earnings by 130.0%, reporting an EPS of $-0.23 versus an estimate of $-0.1.

Revenue was down $0 from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.1 which was followed by a 0.76% increase in the share price the next day.

 

Listen to the earnings announcement yourself by clicking here.

To track all earnings releases for BiondVax Pharmaceuticals visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: BZI-RecapsEarnings